Viatris VTRS
NASDAQ VTRS
$16.49 -0.12 (-0.72%)
As of: Sep 9, 2026 · 2:23 PM EDT

Viatris (VTRS) EBT (2019 - 2026)

Viatris (VTRS) posted EBT of -$64.0 million for Q2 2026, up 74.12% on a QoQ basis from -$247.3 million in Q1 2026, and up 70.52% year-over-year from -$37.5 million in Q2 2025.

Analysis

Viatris (VTRS) EBT (2019 - 2026) Analysis & Trends

Viatris has reported EBT for 8 years, with the latest figure at -$64.0 million in Q2 2026.

  • On a quarterly basis, EBT rose 70.52% year-over-year to -$64.0 million in Q2 2026; TTM through Jun 2026 was -$662.2 million, a 82.34% increase from a year earlier, with the FY2025 full-year figure at -$3.7 billion, down 488.09% from the prior year.
  • EBT was -$64.0 million for Q2 2026 at Viatris, up from -$247.3 million in the prior quarter.
  • The five-year high for EBT was $1.5 billion in Q4 2022, with the low at -$3.1 billion in Q1 2025.
  • Average EBT over 5 years is -$88.0 million, with a median of $41.3 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: EBT soared 820.4% in 2022, then sank 1613.69% in 2025.
  • Over 5 years, EBT stood at $1.5 billion in 2022, then tumbled by 158.21% to -$855.0 million in 2023, then soared by 38.42% to -$526.5 million in 2024, then surged by 34.85% to -$343.0 million in 2025, then surged by 81.34% to -$64.0 million in 2026.
  • The last three EBT figures came in at -$64.0 million (Q2 2026), -$247.3 million (Q1 2026), and -$343.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn -455.00 Mn
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn -64.00 Mn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 58.37 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 70.99 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn 348.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -66.76 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 37.10 Mn
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn 38.54 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn 2.02 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -64.00 Mn
Mar 31, 2026 -247.30 Mn
Dec 31, 2025 -343.00 Mn
Sep 30, 2025 -7.90 Mn
Jun 30, 2025 -217.10 Mn
Mar 31, 2025 -3.10 Bn
Dec 31, 2024 -526.50 Mn
Sep 30, 2024 90.50 Mn
Jun 30, 2024 -391.80 Mn
Mar 31, 2024 204.60 Mn
Dec 31, 2023 -855.00 Mn
Sep 30, 2023 402.20 Mn
Jun 30, 2023 333.00 Mn
Mar 31, 2023 322.70 Mn
Dec 31, 2022 1.47 Bn
Sep 30, 2022 427.50 Mn
Jun 30, 2022 389.30 Mn
Mar 31, 2022 527.50 Mn
Dec 31, 2021 -203.90 Mn
Sep 30, 2021 199.90 Mn